Diabetes News and Research

Latest Diabetes News and Research

Study finds use of retail clinics rising

Researchers from the RAND Corporation found a dramatic increase in adults seeking care at clinics in drugs stores and other outlets.

24 Nov 2011

NIH-led study advances HIV vaccine research

HIV is coated in sugars that usually hide the virus from the immune system. Newly published research reveals how one broadly neutralizing HIV antibody actually uses part of the sugary cloak to help bind to the virus. The antibody binding site, called the V1/V2 region, represents a suitable HIV vaccine target, according to the scientists who conducted the study. In addition, their research reveals the detailed structure of the V1/V2 region, the last part of the virus surface to be visualized at the atomic level.

24 Nov 2011

OECD report finds U.S. pays more by far for health care

The U.S. healthcare system is more effective at delivering high costs than quality care, according to a new study that found first-rate treatment for cancer but insufficient primary care for other ailments. The study, released on Wednesday by the 34-nation Organization for Economic Cooperation and Development, or OECD, said Americans pay more than $7,900 per person for healthcare each year -- far more than any other OECD country -- but still die earlier than their peers in the industrialized world.

24 Nov 2011

MC3R gene plays an important role in maintaining steady weight

Against the backdrop of the growing epidemic of obesity in the United States, scientists from the Florida campus of The Scripps Research Institute have made an important new discovery regarding a specific gene that plays an important role in keeping a steady balance between our food intake and energy expenditure. The study may help scientists better understand the keys to fighting obesity and related disorders such as diabetes.

24 Nov 2011

Physicians can do better if they learn from their failures

When seeking a physician, you should look for one with experience. Right? Maybe not. Research on physicians' decision-making processes has revealed that those who pay attention to failures as well as successes become more adept at selecting the correct treatment.

24 Nov 2011

Takeda submits alogliptin plus metformin NDA to FDA for treatment of type 2 diabetes

Takeda Pharmaceutical Company Limited (Takeda) announced today that its wholly-owned subsidiary Takeda Global Research & Development Center, Inc., U.S., submitted a New Drug Application (NDA) to the United States (U.S.) Food and Drug Administration (FDA) for the fixed-dose combination therapy alogliptin/metformin, which combines alogliptin with metformin in a single tablet.

24 Nov 2011

Metformin prevents growth of breast cancer cells in human cultures

An inexpensive drug that treats Type-2 diabetes has been shown to prevent a number of natural and man-made chemicals from stimulating the growth of breast cancer cells, according to a newly published study by a Michigan State University researcher.

24 Nov 2011

BUSM professor receives 2011 ACN Communication Media Award

Michael F. Holick, PhD, MD, director of the General Clinical Research Unit and professor of medicine, physiology and biophysics at Boston University School of Medicine (BUSM) was selected by the American College of Nutrition (ACN) Awards Committee as the 2011 recipient of the ACN Communication Media Award.

23 Nov 2011

BIOTRONIK announces first implantations of new Lumax 740 ICDs

BIOTRONIK, a leading manufacturer of innovative medical technology, announced today the first implantations of the new Lumax 740 implantable cardiac defibrillators—the world's first and only ICDs eligible for use with magnetic resonance imaging.

23 Nov 2011

Study evaluates how eating habits could impact obesity trends among adults

Too much fast food, poor meal choices and bad eating habits are causing more Canadians to be overweight or obese. Despite this trend, individuals who eat well are 20 per cent less likely to be obese, according to a study by Concordia University economists published in the Journal of Primary Care & Community Health.

23 Nov 2011

Study evaluates safety and effectiveness of Diamondback device for heart attacks

Drilling through concrete to create an opening may sound more like construction than medicine, but the approach is similar to what researchers at Orlando Regional Medical Center (ORMC) are doing in a clinical trial to evaluate a device that breaks through hardened coronary arteries, in an effort to prevent heart attacks and relieve chest pain.

23 Nov 2011

Moderate salt intake may lower risk of cardiovascular events

For years doctors have warned that too much salt is bad for your heart. Now a new McMaster University study suggests that both high and low levels of salt intake may put people with heart disease or diabetes at increased risk of cardiovascular complications.

23 Nov 2011

Families with chronically ill member less likely to benefit from employer-sponsored insurance

Benefits paid out under employer-sponsored health care plans are less generous to families covering a member with a chronic illness than to families without a chronically ill member, according to a trio of university researchers. The difference is due primarily to higher out-of-pocket expenses for prescription drugs.

23 Nov 2011

EpiGen to collaborate with Nestl- Research Center in Switzerland

The EpiGen Consortium, an international alliance of the world's leading epigenetics researchers (Singapore Institute for Clinical Sciences of the Agency for Science, Technology and Research (A*STAR), National University of Singapore, University of Southampton, Medical Research Council - Lifecourse Epidemiology Unit, AgResearch Limited, Auckland UniServices Limited) are pleased to announce the creation of a research collaboration with Nestl- Research Center in Switzerland.

23 Nov 2011

Treatment of Type 1 diabetes patients with DiaPep277- may have several medical benefits

The clinical trial was random, regulated, double-blinded and broad-based. The drug was tested on 457 patients, aged 16-45, who had been diagnosed with Type 1 diabetes a short time before joining the trial. The trial took place in around 40 medical centers in Europe, Israel and South Africa. The patients in the trial were randomly assigned to one of two groups: One received the trial drug (DiaPep277-) through a subcutaneous injection once every three months, for a period of two years, while the control group was given a placebo in the same way.

23 Nov 2011

FDA approves Medtronic's iPro2 Professional continuous glucose monitoring system

Medtronic, Inc. today announced the Food and Drug Administration (FDA) approval of iPro2, a next generation Professional continuous glucose monitoring (CGM) system and the latest in a series of recent diabetes technology approvals and innovations from the company.

From Medtronic 22 Nov 2011

Coffee may protect against womb cancer: Study

For the study the researchers looked at coffee consumption and endometrial cancer risk in more than 67,000 women aged between 34 and 59 enrolled in the long-running Nurses' Health Study. The researchers found that women who took more than four cups of coffee a day over a 26-year period were 25 percent less likely to get the cancer.

22 Nov 2011

Post-surgery death risk high among thinner people: Study

A new study has found that thinner people are at a higher risk of dying within 30 days of an operation than heavier people. The cause behind this trend is not clear.

22 Nov 2011

Diaverum signs joint venture agreement with Nazer Group

November 2011: Diaverum, one of the world´s largest independent renal care providers, has signed a joint venture agreement with Nazer Group, a Saudi Arabian Holding Company with major investments in the medical sector including Bupa Arabia.

22 Nov 2011

New device safe, more effective for patients with chronic neurological conditions

Functional electrical stimulation (FES) was developed to help return lost function to patients with upper and lower extremity injuries and spinal cord injuries, among other applications. However, the devices, which work by stimulating neuronal activity in nerve-damaged patients, have a potential shortcoming in that the electrical currents needed for the treatment to work can also send errant signals to surrounding nerves, resulting in painful side effects.

22 Nov 2011

Diabetes News and Research

Latest Diabetes News and Research

Study finds use of retail clinics rising

NIH-led study advances HIV vaccine research

OECD report finds U.S. pays more by far for health care

MC3R gene plays an important role in maintaining steady weight

Physicians can do better if they learn from their failures

Takeda submits alogliptin plus metformin NDA to FDA for treatment of type 2 diabetes

Metformin prevents growth of breast cancer cells in human cultures

BUSM professor receives 2011 ACN Communication Media Award

BIOTRONIK announces first implantations of new Lumax 740 ICDs

Study evaluates how eating habits could impact obesity trends among adults

Study evaluates safety and effectiveness of Diamondback device for heart attacks

Moderate salt intake may lower risk of cardiovascular events

Families with chronically ill member less likely to benefit from employer-sponsored insurance

EpiGen to collaborate with Nestl- Research Center in Switzerland

Treatment of Type 1 diabetes patients with DiaPep277- may have several medical benefits

FDA approves Medtronic's iPro2 Professional continuous glucose monitoring system

Coffee may protect against womb cancer: Study

Post-surgery death risk high among thinner people: Study

Diaverum signs joint venture agreement with Nazer Group

New device safe, more effective for patients with chronic neurological conditions

Genomics - Industry Focus eBook (2nd edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Diabetes News and Research

Latest Diabetes News and Research

Genomics - Industry Focus eBook (2nd edition) eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in